Repligen Corporation
Organization details
- Legal name
- Repligen Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Waltham
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RGEN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000730272
- EIN
- 04-2729386
Board of directors
-
Anthony Hunt · Director · Chief Executive OfficerSince 2023
-
Glenn P. Muir · DirectorSince 2023
-
Karen A. Dawes · DirectorSince 2023
-
Konstantin Konstantinov · DirectorSince 2023
-
Manner Carrie Eglinton · DirectorSince 2023
-
Margaret Pax · DirectorSince 2024
- Since 2023
-
Nicolas Barthelemy · DirectorSince 2023
-
Olivier Loeillot · Director · Chief Executive OfficerSince 2024
-
Rohin Mhatre · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
74.4%
-
82.4%
-
98.4%
-
98.6%
-
99.4%
-
99.6%
-
99.8%
Board connections
4 of this board's directors also sit on 9 other boards. 5 are in the same sector.
- via Anthony Hunt
- via Martin D. Madaus
-
BioLife Solutions Inc. Same sectorvia Anthony Hunt
- via Glenn P. Muir
-
Haemonetics Corporation Same sectorvia Martin D. Madaus
-
Neuronetics Inc. Same sectorvia Glenn P. Muir
-
OraSure Technologies Inc. Same sectorvia Manner Carrie Eglinton
- via Martin D. Madaus
-
Standard BioTools Inc. Same sectorvia Martin D. Madaus
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $15,262,289
- 25 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Douglass Brian Robb Officer (CHIEF PRODUCT OFFICER) | Grant or award | +700 | — | — |
| Oct 5, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −1,333 | $178.75 | $238,274 |
| Oct 5, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Option exercise | +4,202 | $154.96 | $651,142 |
| Oct 5, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −4,202 | $190.00 | $798,380 |
| Oct 2, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Shares withheld for tax | −1,248 | $181.70 | $226,762 |
| Sep 25, 2026 | Garland Jason K Officer (CFO) | Shares withheld for tax | −421 | $189.68 | $79,855 |
| Sep 24, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Option exercise | +8,404 | $154.96 | $1,302,284 |
| Sep 24, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −8,404 | $190.00 | $1,596,760 |
| Sep 24, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Option exercise | +4,542 | $155.38 | $705,736 |
| Sep 24, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −4,542 | $190.00 | $862,980 |
| Sep 21, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Option exercise | +5,426 | $141.79 | $769,353 |
| Sep 21, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −5,426 | $180.00 | $976,680 |
| Sep 4, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Open-market sale | −3,035 | $165.90 | $503,507 |
| Sep 3, 2026 | Olivier Loeillot Director, Officer (Chief Executive Officer) | Shares withheld for tax | −2,842 | $169.61 | $482,032 |
| Sep 1, 2026 | Hughes Violetta Officer (CHIEF ACCOUNTING OFFICER) | Shares withheld for tax | −277 | $170.02 | $47,096 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Repligen Corporation
Who is the CEO of Repligen Corporation?
Anthony Hunt is Repligen Corporation's Chief Executive Officer.
How many directors are on Repligen Corporation's board?
Repligen Corporation's board has 10 directors: Anthony Hunt, Glenn P. Muir, Karen A. Dawes, Konstantin Konstantinov, Manner Carrie Eglinton, Margaret Pax, Martin D. Madaus, Nicolas Barthelemy, Olivier Loeillot and Rohin Mhatre.
Are Repligen Corporation insiders buying or selling shares?
Over the last 12 months, Repligen Corporation insiders made no open-market purchases and sold $15.3 million of shares in 25 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="repligen-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.